VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-01723 Package ID: USCOURTS-cofc-1_20-vv-01723 Petitioner: Stacey Beckerley Filed: 2020-12-01 Decided: 2025-05-09 Vaccine: influenza Vaccination date: 2017-12-28 Condition: peripheral neuropathy; small fiber neuropathy Outcome: compensated Award amount USD: 45000 AI-assisted case summary: Stacey Beckerley filed a petition on December 1, 2020, alleging that she suffered peripheral neuropathy as a result of an influenza vaccine received on December 28, 2017. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused her alleged peripheral neuropathy, small fiber neuropathy, or any other injury, and denied that her current condition was a sequelae of a vaccine-related injury. Despite the respondent's denials, the parties reached a stipulation recommending an award of compensation. Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it as the decision of the Court. Petitioner was awarded a lump sum of $45,000.00 to compensate for all damages. The parties agreed to waive their right to seek review, allowing for expedited judgment. Petitioner's counsel was Michael G. McLaren of Black McLaren, et al., PC. Respondent's counsel was Elizabeth Andary of the U.S. Department of Justice. Theory of causation field: Petitioner Stacey Beckerley alleged that an influenza vaccine administered on December 28, 2017, caused peripheral neuropathy and small fiber neuropathy. The respondent denied causation. The parties reached a stipulation for an award of $45,000.00. The theory of causation was not described in detail in the public decision, but the stipulation indicates an "Off-Table" theory was pursued. Special Master Nora Beth Dorsey adopted the stipulation, and judgment was entered based on the parties' agreement. Petitioner was represented by Michael G. McLaren, and Respondent by Elizabeth Andary. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_20-vv-01723-0 Date issued/filed: 2025-06-03 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 5/9/2025) regarding 99 DECISION Stipulation. Signed by Special Master Nora Beth Dorsey. (aevw) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: May 9, 2025 * * * * * * * * * * * * * * * STACEY BECKERLEY, * * Petitioner, * No. 20-1723V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; Influenza AND HUMAN SERVICES, * (“Flu”) Vaccine; Peripheral Neuropathy; * Small Fiber Neuropathy. * Respondent. * * * * * * * * * * * * * * * * Michael G. McLaren, Black McLaren, et al., PC, Memphis, TN, for Petitioner. Elizabeth Andary, U.S. Department of Justice, Washington, DC, for Respondent. DECISION BASED ON STIPULATION1 On December 1, 2020, Stacey Beckerley (“Petitioner”) filed a petition in the National Vaccine Injury Program2 alleging that she suffered peripheral neuropathy as a result of an influenza (“flu”) vaccine she received on December 28, 2017. Petition at Preamble (ECF No. 1). On May 9, 2025, the parties filed a stipulation recommending an award of compensation to Petitioner. Stipulation (ECF No. 98). Respondent denies that the flu vaccine is the cause of Petitioner’s alleged peripheral neuropathy, small fiber neuropathy, or any other injury; and 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 1 Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 2 of 7 denies that her current condition is a sequelae of a vaccine-related injury. Id. at ¶ 6. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that Petitioner shall receive the following compensation: (1) A lump sum of $45,000.00 to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). Stipulation at ¶ 8. The undersigned approves the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 3 of 7 Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 4 of 7 Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 5 of 7 Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 6 of 7 Case 1:20-vv-01723-UNJ Document 103 Filed 06/03/25 Page 7 of 7 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_20-vv-01723-cl-extra-11064024 Date issued/filed: 2025-06-03 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10597436 -------------------------------------------------------------------------------- In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: May 9, 2025 * * * * * * * * * * * * * * * STACEY BECKERLEY, * * Petitioner, * No. 20-1723V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; Influenza AND HUMAN SERVICES, * (“Flu”) Vaccine; Peripheral Neuropathy; * Small Fiber Neuropathy. * Respondent. * * * * * * * * * * * * * * * * Michael G. McLaren, Black McLaren, et al., PC, Memphis, TN, for Petitioner. Elizabeth Andary, U.S. Department of Justice, Washington, DC, for Respondent. DECISION BASED ON STIPULATION 1 On December 1, 2020, Stacey Beckerley (“Petitioner”) filed a petition in the National Vaccine Injury Program 2 alleging that she suffered peripheral neuropathy as a result of an influenza (“flu”) vaccine she received on December 28, 2017. Petition at Preamble (ECF No. 1). On May 9, 2025, the parties filed a stipulation recommending an award of compensation to Petitioner. Stipulation (ECF No. 98). Respondent denies that the flu vaccine is the cause of Petitioner’s alleged peripheral neuropathy, small fiber neuropathy, or any other injury; and 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 1 denies that her current condition is a sequelae of a vaccine-related injury. Id. at ¶ 6. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that Petitioner shall receive the following compensation: (1) A lump sum of $45,000.00 to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). Stipulation at ¶ 8. The undersigned approves the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation. 3 IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2